|
|
||||||||
Nuclear Medicine |
1 From the Departments of Radiology (G.J.S., G.W., H.S., R.G., R.N., R.M.A.), Surgery (A.M., F.M.S.J.), and Pulmonology (G.F.), University Hospital Graz, Auenbruggerplatz 9, A-8036 Graz, Austria; and Department of Pulmonology, County Hospital Hörgas-Enzenbach, Gratwein, Austria (M.W.). Received May 25, 2003; revision requested July 17; final revision received October 29; accepted November 6. Address correspondence to G.J.S. (e-mail: gottfried.schaffler@kfunigraz.ac.at).
PURPOSE: To evaluate the accuracy of fluorine 18 fluorodeoxyglucose (FDG) positron emission tomography (PET) in differentiation of pleural malignancy and cancer-unrelated pleural disease in patients with nonsmall cell lung cancer (NSCLC) and pleural abnormalities at computed tomography (CT).
MATERIALS AND METHODS: In 92 patients, pleural abnormalities were detected at contrast materialenhanced thoracic CT, which was performed for newly diagnosed NSCLC (n = 41) or restaging (n = 51). CT findings were negative for pleural malignancy when pleural effusion with attenuation of 10 HU or less and/or rib fractures with no evidence of pathologic fracture were present; findings were indeterminate when pleural effusion with attenuation greater than 10 HU and/or solid pleural abnormalities without osseous destruction of the chest wall were present; and findings were positive if any osseous destruction of the chest wall adjacent to a pleural mass was present. All patients underwent FDG PET. Findings were negative for pleural malignancy if pleural activity was absent, equal to, or less than mediastinal background activity; findings were positive if pleural activity was higher than mediastinal background activity. Reading of CT and FDG PET scans was first performed separately and then was combined. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPP), and accuracy were calculated for CT and FDG PET separately and for CT and FDG PET combined, with cytologic and/or histologic analysis as standard of reference.
RESULTS: In detection of pleural malignancies, CT findings were indeterminate in 65 (71%) patients and true-negative in 27 (29%). Respective sensitivity, specificity, PPV, NPV, and accuracy of FDG PET in detection of pleural malignancies were 100%, 71%, 63%, 100%, and 80%; and those of CT and FDG PET combined, 100%, 76%, 67%, 100%, and 84%.
CONCLUSION: Findings suggest that a negative FDG PET scan for indeterminate pleural abnormalities at CT indicates a benign character, while positive findings on an FDG PET scan are sensitive for malignancy.
© RSNA, 2004
Index terms: Lung neoplasms, 60.321, 60.33 Lung neoplasms, CT, 60.12112, 60.12115 Lung neoplasms, PET, 60.12163 Pleura, CT, 66.12112 Pleura, neoplasms, 66.317, 66.33 Pleura, PET, 66.12163
This article has been cited by other articles:
![]() |
J. E. Heffner and J. S. Klein Recent Advances in the Diagnosis and Management of Malignant Pleural Effusions Mayo Clin. Proc., February 1, 2008; 83(2): 235 - 250. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Bunyaviroch and R. E. Coleman PET Evaluation of Lung Cancer J. Nucl. Med., March 1, 2006; 47(3): 451 - 469. [Full Text] [PDF] |
||||
![]() |
R. F. Munden, S. S. Swisher, C. W. Stevens, and D. J. Stewart Imaging of the Patient with Non-Small Cell Lung Cancer Radiology, December 1, 2005; 237(3): 803 - 818. [Abstract] [Full Text] [PDF] |
||||